Results 91 to 100 of about 2,755,321 (217)

Clinical guideline highlights for the hospitalist: Updates on the treatment of drug‐susceptible and drug‐resistant tuberculosis

open access: yes
Journal of Hospital Medicine, EarlyView.
Allison Stickles   +3 more
wiley   +1 more source

Bacterial Diseases in Farmed Nile Tilapia (Oreochromis niloticus): A Review of Pathogenesis, Immune Responses and Recent Advances in Diagnostics and Management

open access: yesAquaculture, Fish and Fisheries, Volume 6, Issue 5, October 2026.
Pathogenesis of bacterial diseases in Nile tilapia and anti‐bacterial mechanisms. ABSTRACT Nile tilapia (Oreochromis niloticus) is among the most widely farmed fish globally that plays a major role in ensuring food security in many low‐ and middle‐income countries.
Catherine Agoe   +8 more
wiley   +1 more source

Effectiveness of isoniazid preventive therapy on the incidence of tuberuculosi in people living with HIV in Rwanda [PDF]

open access: yes, 2016
Session presented on Sunday, July 24, 2016: Purpose: The purpose of this study was to evaluate the effectiveness of primary Isoniazid Preventive Therapy (IPT) on the incidence of active Tuberculosis (TB), in adult People Living with Human Immuno ...
Uwamahoro, Marie Claire
core   +1 more source

Predictors of adherence to isoniazid preventive therapy among HIV positive adults in Addis Ababa, Ethiopia

open access: yesBMC Public Health, 2011
Background Isoniazide preventive therapy (IPT) is given to individuals with latent infection of tuberculosis (TB) to prevent the progression to active disease. One of the primary reasons for failure of IPT is poor adherence.
Mindachew Mesele   +3 more
doaj   +1 more source

Molecular Diagnostics for WHO Priority Bacterial Pathogens: A Bibliometric Mapping of Diagnostic Platforms, Resistance Markers, and Antimicrobial Resistance Research Trends

open access: yesMicrobiologyOpen, Volume 15, Issue 5, October 2026.
This bibliometric mapping of 1746 publications (2000–2025) charts molecular diagnostics for WHO priority bacterial pathogens across platforms, targets, and resistance markers. Conventional PCR/NAAT and whole‐genome sequencing emerge as complementary core platforms, and the field evolves from targeted pathogen detection into an AMR‐centered ...
Selahattin Ünlü
wiley   +1 more source

Post‐Tuberculosis Lung Disease: Clinicopathologic Insights, Diagnosis, Prevention, and Management

open access: yesMedComm, Volume 7, Issue 10, October 2026.
A comprehensive review on post‐tuberculosis lung disease (PTLD) addresses the epidemiology, pathogenesis, clinical phenotypes and management, risk factors, prevention and systems approach, and future directions. This review provides standardized definitions, mechanistic insights and biomarkers of PTLD development, and clinical strategies for PTLD ...
Radha Gopalaswamy, Selvakumar Subbian
wiley   +1 more source

What Proportion of New Tuberculosis Patients Has a History of Household Tuberculosis Exposure? A Cross-Sectional Study from Udupi District, South India

open access: yesTropical Medicine and Infectious Disease, 2019
While tuberculosis (TB) preventive therapy among household contacts is effective at an individual level, its population-level impact on reducing TB incidence has been unclear. In this study, we aimed to assess, among the new tuberculosis patients started
Chidananda Sanju SV   +4 more
doaj   +1 more source

Bacteria‐Responsive Nanostructured Drug Delivery Systems for Targeted Antimicrobial Therapy

open access: yesAdvanced Materials, Volume 38, Issue 51, 11 September 2026.
Bacteria‐responsive nanocarriers are designed to release antimicrobials only in the presence of infection‐specific cues. This selective activation ensures drug release precisely at the site of infection, avoiding premature or indiscriminate release, and enhancing efficacy.
Guillermo Landa   +3 more
wiley   +1 more source

An open-label cluster-randomised trial on TB preventive therapy for children

open access: yesIJTLD Open
BACKGROUND: In a study on 9 months of isoniazid preventive therapy (IPT) in children in Guinea-Bissau, 76% of children exposed to TB at home completed 6 months of IPT.
G. Lemvik   +6 more
doaj   +1 more source

Adverse events reported among child and adolescent contacts receiving isoniazid preventive therapy (N = 48).

open access: yes, 2019
Adverse events reported among child and adolescent contacts receiving isoniazid preventive therapy (N = 48).
Carmen C. Contreras (845909)   +5 more
core   +1 more source

Home - About - Disclaimer - Privacy